Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea
· Delayed Price · Currency is KRW 5,010.00
+65.00 (1.31%)
Mar 10, 2026, 11:20 AM KST
Bukwang Pharmaceutical Revenue
Bukwang Pharmaceutical had revenue of 47.81B KRW in the quarter ending September 30, 2025, with 12.25% growth. This brings the company's revenue in the last twelve months to 184.38B, up 32.72% year-over-year. In the year 2024, Bukwang Pharmaceutical had annual revenue of 160.09B with 27.13% growth.
Revenue (ttm)
184.38B
Revenue Growth
+32.72%
P/S Ratio
2.65
Revenue / Employee
299.81M
Employees
615
Market Cap
487.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 160.09B | 34.16B | 27.13% |
| Dec 31, 2023 | 125.93B | -64.98B | -34.04% |
| Dec 31, 2022 | 190.91B | 8.42B | 4.61% |
| Dec 31, 2021 | 182.49B | 12.83B | 7.56% |
| Dec 31, 2020 | 169.66B | 1.47B | 0.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EuBiologics | 96.04B |
| Dong-A ST | 770.63B |
| FutureChem Co.,Ltd | 18.75B |
| Shinpoong Pharmaceutical Co.,Ltd | 231.90B |
| Humedix | 110.99B |
| Dong-A Socio Holdings | 1,404.83B |
| JW Pharmaceutical | 764.21B |
| Yungjin Pharm. | 158.79B |